ABSTRACT Urinary volume was related to urinary concentrations of lead, delta-aminolaevulinic acid (ALA), coproporphyrin (COPRO), creatinine, and total solutes in nine lead workers. On a log scale, linear relationships were found between urinary volume and the urinary concentrations. There was a certain difference in the extent of the effects of urinary volume on the urinary concentrations. For example, the concentration of creatinine was more affected by urinary volume than those of lead, ALA, and total solutes among the substances examined: similarly, the concentration of COPRO more than that of ALA. An equation was introduced to eliminate the effects of urinary volume on urinary concentrations. The effects of urinary volume on the concentrations adjusted to urinary specific gravity, osmolality, and creatinine are discussed in the light of these findings. 
Urinary lead, delta-aminolaevulinic acid (ALA), and coproporphyrin (COPRO), among the indicators of the dose and effects of lead, necessitate measuring the urinary concentrations. It has been known for many years that these concentrations vary over a wide range and are inversely correlated with urinary volume throughout each 24-hour period. No factor other than urinary volume seems to play any important part in the induction of the variation.1
It remains unclear, however, to what extent those concentrations are affected by urinary volume. The excretion of lead, ALA, and total solutes was found to decrease when urinary volume was reduced: conversely, that of COPRO and creatinine was independent of urinary volume.2 This observation suggested that the effect of urinary volume is greater on the concentrations of COPRO and creatinine than on those of lead, ALA, and total solutes. A further assumption is that the extent of the effect of urinary volume can be quantitatively different among those substances.
In this paper the relationships between urinary volume and urinary concentrations of lead, ALA, 
Subjects and methods

SUBJECTS
Nine male lead workers (plastics worker, lead smelter, welder, pigment maker, type founder, paint maker, galvaniser, and two stereotype founders) were admitted to hospital for diagnosis, prophylaxis, or treatment of lead poisoning. At the time of examination, six subjects had not been exposed to lead for more than three weeks; the two subjects (1 and 4) for five days; and one subject (No 9) for three days. Blood lead concentrations ranged from 0 3 ,umol/l (7 ,ugldl) to 2-9 ,umol/l (61 ,tg/dl) (mean 1-7 ,umol/l (35 = 0: n was the number of observations; n -2, degree of freedom for t-test; fi, the regression coefficient in the underlying population; and SE(b), the estimated standard error of the sample regression coefficient. The difference in the regression coefficients among subjects was tested by analysis of covariance using F-test under the null hypothesis Ho:f 1 = P2 = ----8 n, where i, f2, ---, and fin were regression coefficients in each underlying population. The difference in the regression coefficient between two urinary substances was tested by paired comparison using the t-test. Table 1 shows the daily variation in urinary concentrations of lead, ALA, COPRO, and creatinine; urinary specific gravity; urinary osmolality; and urinary volume in each subject.
Results
EFFECTS OF URINARY VOLUME ON URINARY CONCENTRATIONS
The urinary concentrations were inversely correlated with the corresponding urinary volume, and linear log U = a -b log V, where U represents the urinary concentration of the substance examined; V, urinary volume; and b, regression coefficient.
The regression coefficient (b) was significant in all the subjects examined for creatinine; in all but one subject for lead, ALA, total solutes (g/l), and total solutes (mol/kg H20); and in five subjects for COPRO (table 2). The lack of statistical significance in some cases may be due to the small number of observations, especially in subject 6. Non-significant differences in the b value among subjects were found for lead, ALA, COPRO, and creatinine (table 2) . The mean b value for creatinine was significantly greater than those for lead, ALA, total solutes (g/l), and total solutes (mol/kg H20): similarly, the mean for COPRO was greater than that for ALA (tables 2 and 3).
INTRODUCTION OF AN EQUATION TO ELIMINATE THE EFFECT OF URINARY VOLUME
The equation: log Ui = a -b log Vi was transformed into Ui Vib = k, where i represents a sampling number of urine in each subject; and k, a constant. Selecting U(v = 1) at Vi = 1 ml/min, the equation introduced became as follows:
where U(v = 1) represents the concentration adjusted to one mililitre urinary volume per minute; Ui, the urinary concentration of the substance examined; and Vi, observed urinary volume (ml/min).
When the b value is equal to 10, the equation is simplified as U(v = 1) = Ui -Vi. This equation means that the timed excretion of a urinary substance (mol/min) is not affected by urinary volume since Ut -Vi is equal to the timed excretion of a urinary substance and U(v = 1) is a constant in a single subject. When the b value approaches 0, on the other hand, the equation becomes Ui = a constant [Uv = 1)]. In this extreme case the timed excretion varies greatly according to the change of urinary volume since the timed excretion (Ui * Vi) is determined by urinary volume (V1). Thus the b value indicates how much the timed excretion as well as the concentration of urinary substance is affected by urinary volume. In this study, therefore, the timed excretion of lead, ALA, and total solutes was more affected by urinary volume than that of creatinine: similarly, the timed excretion of ALA more than that of COPRO. To minimise the effects of urinary volume on urinary lead concentrations, three methods have been practised: (1) Collection of 24-h urinary samples.5 (2) Calculations of lead excretion as mass of lead per gram of total urinary solutes-that is, concentration adjusted to specific gravity of urine.6 7 (3) Adjustment to urinary creatinine excretion.8 Evidence was found in this study, however, that none of the methods were free from the effect of urinary volume. Firstly, both the total excretion2 and the concentration of lead in 24-h urinary samples were affected by urinary volume. Secondly, even the concentrations adjusted to total urinary solutes or Araki creatinine would be affected by urinary volume to some extent because of different effects of urinary volume on the concentrations of lead, ALA, COPRO, total solutes, and creatinine: the former three concentrations give a numerator and the latter two a denominator for the calculation of adjusted concentrations. The newly introduced equation, therefore, should be applied because (1) the relationships between urinary volume and urinary concentrations, from which the equation was introduced, were so strong; and (2) 
